Literature DB >> 30579512

Resource Utilization Among Adult Congenital Heart Failure Admissions in Pediatric Hospitals.

Jonathan Chan1, Ronnie Thomas Collins2, Matt Hall3, Anitha John4.   

Abstract

We sought to analyze the trends and resource utilization of adult congenital heart disease (ACHD)-related heart failure admissions at children's hospitals. Heart failure admissions in patients with ACHD continue to rise at both pediatric and adult care facilities. Data from the Pediatric Health Information Systems database (2005 to 2015) were used to identify patients (≥18 years) admitted with congenital heart disease (745.xx-747.xx) and principal diagnosis of heart failure (428.xx). High resource use (HRU) admissions were defined as those over the 90th percentile. There were 562 admissions (55.9% male) across 39 pediatric hospitals. ACHD-related heart failure admissions increased from 4.1% in 2006 to 6.3% in 2015 (p = 0.015). Median hospital charge for ACHD-related heart failure admissions was $59,055 [IQR $26,633 to $156,846]. Total charges increased with more complex anatomic category (p = 0.049). Though HRU admissions represented 10% of ACHD-related heart failure admissions, they accounted for >66% of the total charges. The median total hospital charges for HRU admissions were $1,018,656 [IQR $722,574 to $1,784,743], compared with $58,890 [IQR $26,456 to $145,890] for non-HRU admissions (p < 0.001). Inpatient mortality rate (26.3% vs 4.0%) and the presence of ≥2 comorbidities (68% vs 31%) were higher for HRU admissions (p < 0.001). On multivariable analysis, technology dependence (aOR: 4.4, p < 0.001) and renal comorbidities (aOR: 3.0, p = 0.04) were associated with HRU. In conclusion, heart failure-related ACHD admissions in pediatric hospitals are increasing. Compared with non-HRU, HRU admissions had higher inhospital mortality and greater comorbidities. Additional care strategies to reduce resource use among these patients and improve overall quality of care merits further study.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Year:  2018        PMID: 30579512     DOI: 10.1016/j.amjcard.2018.11.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Epidemiology of Pediatric Heart Failure in the USA-a 15-Year Multi-Institutional Study.

Authors:  Marc Anders; Susan Denfield; Raysa Morales-Demori; Elena Montañes; Gwen Erkonen; Michael Chance
Journal:  Pediatr Cardiol       Date:  2021-04-19       Impact factor: 1.655

2.  Pulsed Levosimendan in advanced heart failure due to congenital heart disease: a case series.

Authors:  James Cranley; Antonia Hardiman; Leisa J Freeman
Journal:  Eur Heart J Case Rep       Date:  2020-05-01

3.  Clinical Outcomes During Admissions for Heart Failure Among Adults With Congenital Heart Disease.

Authors:  Anushree Agarwal; Carson W Dudley; Gregory Nah; Robert Hayward; Zian H Tseng
Journal:  J Am Heart Assoc       Date:  2019-08-17       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.